Expanding the phenotypic and genetic spectrum of GTPBP3 deficiency: findings from nine Chinese pedigrees
Open Access
- 24 December 2024
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 19 (1) , 1-13
Abstract
Background: GTPBP3 catalyzes τm5(s2) U biosynthesis at the 34th wobble position of mitochondrial tRNAs, the hypomodification of τm5U leads to mitochondrial disease. While twenty-three variants of GTPBP3 have been reported worldwide, the genetic landscape in China remains uncertain. Methods: By using whole-exome sequencing, the candidate individuals carrying GTPBP3 variants were screened and identified. Pathogenicity analysis of variants was biochemically verified by patients-derived immortalized lymphocytes and cell models. Results: Through whole-exome sequencing, thirteen variants associated with GTPBP3 were identified in nine Chinese pedigrees, with eight of these variants being newly reported. Affected individuals displayed classic neurologic phenotypes and heart complications including developmental delay, seizures, hypotonia, exercise intolerance, and hypertrophic cardiomyopathy. Additionally, they displayed new symptoms such as eye problems like strabismus and heart issues related to valve function. Studies conducted on patient-derived cells provided evidence of reduced levels of GTPBP3 and impairment in mitochondrial energetic biogenesis. Re-expressing GTPBP3 variants in knockout cell lines further defined the pathogenicity of the novel variants. Analysis of the genetic spectrum in the Chinese population highlighted a concentration in exons 4 and 6, with c.689A > C being the prominent hotspot. Conclusion: Our findings emphasize the extensive clinical and genetic implications of GTPBP3-related mitochondrial disorders, particularly within the Chinese population, but further investigations are needed to explore the phenotype-genotype correlation.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82302618, 82072366)
- National Key Research and Development Program of China (2021YFC2700900, 2017YFC1001700)
- China Postdoctoral Science Foundation (2023M743124)
- the Key Discipline of Zhejiang Province in Public Health and Preventive Medicine (Hangzhou Medical College)
- the Key Discipline of Zhejiang Province in Medical Technology (Wenzhou Medical University)
This publication has 47 references indexed in Scilit:
- Biallelic variants in GTPBP3: New patients, phenotypic spectrum, and outcomeAnnals of Clinical and Translational Neurology, 2024
- Variant interpretation using population databases: Lessons from gnomADHuman Mutation, 2021
- Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significanceThe American Journal of Human Genetics, 2021
- In silico screening and molecular dynamics simulation of deleterious PAH mutations responsible for phenylketonuria genetic disorderProteins: Structure, Function, and Bioinformatics, 2021
- Mitochondrial DNA copy number in human disease: the more the better?FEBS Letters, 2020
- Mitochondrial genome variant m.3250T>C as a possible risk factor for mitochondrial cardiomyopathyHuman Mutation, 2020
- Comparison of clinical parameters with whole exome sequencing analysis results of autosomal recessive patients; a center experienceMolecular Biology Reports, 2018
- The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human diseaseCellular and Molecular Life Sciences, 2017
- Mutations in GTPBP3 Cause a Mitochondrial Translation Defect Associated with Hypertrophic Cardiomyopathy, Lactic Acidosis, and EncephalopathyThe American Journal of Human Genetics, 2014
- Mitochondria: Mitochondrial OXPHOS (dys) function ex vivo – The use of primary fibroblastsThe International Journal of Biochemistry & Cell Biology, 2014